MUMBAI, Nov 27 (Reuters) - Indian drugmaker Dr Reddy's Laboratories Ltd has received a letter from the U.S. Food and Drug administration highlighting concerns about its manufacturing plant in the southern Indian state of Andhra Pradesh, the ... Yahoo! Finance, 3 weeks ago
Dr Reddy's says FDA raises concerns about plant - Business Standard India, 3 weeks ago
Comment · print · T T T+· T- Doreswamy and others show solidarity towards people of Kolar Hundreds of people from Kolar on Thursday staged a dharna at Freedom Park in Bengaluru demanding revocation of D.K. Ravi's transfer order and ...The Hindu, 1 month ago
on your WebpageAdd Widget >Get your members hooked!